DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
Approval overview DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE is listed in Drugs@FDA under application 086440 (ANDA).
Marketing status: Discontinued Active ingredient ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE Form and strength CAPSULE;ORAL - 0.025MG;2.5MG Sponsor SCHERER RP Submission history Latest submission status date: 1981-04-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE is listed in Drugs@FDA under application 086440 (ANDA). Marketing status: Discontinued Active ingredient ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE Form and strength CAPSULE;ORAL - 0.025MG;2.5MG Sponsor SCHERER RP Submission history Latest submission status date: 1981-04-06 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.